Jens Klein AMSilk
Jens Klein is the Managing Director and CEO of AMSilk, the leading global producer of silk biopolymers and a pioneer in biofabrication. As CEO of AMSilk, Jens oversees strategy and execution for all three of AMSilk’s business units: fibers (Biosteel), cosmetics and med-tech.
A veteran of the polymer industry, Mr. Klein previously served on as a member of the Managing Board of nanoresins AG and Hanse Chemie AG, which were both acquired by Evonik Industries AG in 2011. Jens went on to serve in leading managing functions at Evonik before joining AMSilk.
Prior to that, Mr. Klein was a member of the Managing Board of the holding company Mulligan BioCapital AG where he played a key role in two initial public offerings of portfolio companies at NASDAQ, one initial public offering at Prime Standard in Frankfurt as well as trade sales to strategic investors. Before joining Mulligan, he was with Fresenius AG, Bad Homburg, where he headed subsidiaries as CEO or CFO. Mr. Klein is a graduate of the University of Mannheim and has an MBA of the Zicklin School of Business, City University of New York.